AAAAAA

   
Results: 1-21 |
Results: 21

Authors: JAKUS V RIETBROCK N HRNCIAROVA M
Citation: V. Jakus et al., STUDY OF INHIBITION OF PROTEIN GLYCATION BY FLUORESCENCE SPECTROSCOPY, Chemicke zvesti, 52, 1998, pp. 446-446

Authors: THURMANN PA KENEDI P SCHMIDT A HARDER S RIETBROCK N
Citation: Pa. Thurmann et al., INFLUENCE OF THE ANGIOTENSIN-II ANTAGONIST VALSARTAN ON LEFT-VENTRICULAR HYPERTROPHY IN PATIENTS WITH ESSENTIAL-HYPERTENSION, Circulation, 98(19), 1998, pp. 2037-2042

Authors: SCHRODTER A LOEW D SCHWANKL W RIETBROCK N
Citation: A. Schrodter et al., VALIDITY OF PHARMACOKINETIC DATA OF BETA-ESCIN FROM HORSE CHESTNUT SEMED EXTRACTS DETERMINED BY RADIOIMMUNOLOGICAL METHODS, Arzneimittel-Forschung, 48(9), 1998, pp. 905-910

Authors: THURMANN P RIETBROCK N
Citation: P. Thurmann et N. Rietbrock, WHY IS THERE NO LONG-ACTING FORM OF CAPTO PRIL, Deutsche Medizinische Wochenschrift, 121(34-35), 1996, pp. 1072-1072

Authors: RIETBROCK N
Citation: N. Rietbrock, PROFESSOR KEWITZ,HELMUT 75, International journal of clinical pharmacology and therapeutics, 34(2), 1996, pp. 89-89

Authors: MARSCHNER JP RIETBROCK N
Citation: Jp. Marschner et N. Rietbrock, RECOMMENDATIONS FOR TREATMENT WITH INTRAV ENOUS IMMUNOGLOBULINS, Medizinische Klinik, 91(3), 1996, pp. 141-147

Authors: THURMANN PA STEPHENS N HEAGERTY AM KENEDI P WEIDINGER G RIETBROCK N
Citation: Pa. Thurmann et al., INFLUENCE OF ISRADIPINE AND SPIRAPRIL ON LEFT-VENTRICULAR HYPERTROPHYAND RESISTANCE ARTERIES, Hypertension, 28(3), 1996, pp. 450-456

Authors: RIETBROCK N
Citation: N. Rietbrock, ON THE 75TH BIRTHDAY OF KEWITZ,HELMUT, Der Internist, 37(2), 1996, pp. 196-196

Authors: MARSCHNER JP RIETBROCK N
Citation: Jp. Marschner et N. Rietbrock, OXYGEN RELEASE KINETICS IN HEALTHY-SUBJECTS AND DIABETIC-PATIENTS .2.EFFECTS OF HBCO, International journal of clinical pharmacology and therapeutics, 33(5), 1995, pp. 263-265

Authors: WELLER S THURMANN P RIETBROCK N GOSSMANN J SCHEUERMANN EH
Citation: S. Weller et al., HPLC ANALYSIS OF AZATHIOPRINE METABOLITES IN RED-BLOOD-CELLS, PLASMA AND URINE IN RENAL-TRANSPLANT RECIPIENTS, International journal of clinical pharmacology and therapeutics, 33(12), 1995, pp. 639-645

Authors: BRECHT JG JENKE A KOHLER ME HARDER S THURMAN P RIETBROCK N
Citation: Jg. Brecht et al., RECOMMENDATIONS OF THE GERMAN-SOCIETY-OF- -CONDUCT-AND-EVALUATION-OF-PHARMACOLOGICAL-STUDIES, Medizinische Klinik, 90(9), 1995, pp. 541-546

Authors: FROLICH JC KIRCH WP RIETBROCK N ROOTS I GUNDERTREMY U
Citation: Jc. Frolich et al., COMMENTS FROM CHAIRS OF INSTITUTES OF CLINICAL-PHARMACOLOGY IN GERMANY, Trends in pharmacological sciences, 15(11), 1994, pp. 410-410

Authors: THEILIG C BERND A RAMIREZBOSCA A GORMAR FF BEREITERHAHN J KELLERSTANISLAWSKI B SEWELL AC RIETBROCK N HOLZMANN H
Citation: C. Theilig et al., REACTIONS OF HUMAN KERATINOCYTES IN-VITRO AFTER APPLICATION OF NICOTINE, Skin pharmacology, 7(6), 1994, pp. 307-315

Authors: MARSCHNER JP THURMANN P HARDER S RIETBROCK N
Citation: Jp. Marschner et al., DRUG UTILIZATION REVIEW ON A SURGICAL INTENSIVE-CARE UNIT, International journal of clinical pharmacology and therapeutics, 32(9), 1994, pp. 447-451

Authors: MARSCHNER JP SEIDLITZ T RIETBROCK N
Citation: Jp. Marschner et al., EFFECT OF 2,3-DIPHOSPHOGLYCERATE ON O-2-DISSOCIATION KINETICS OF HEMOGLOBIN AND GLYCOSYLATED HEMOGLOBIN USING THE STOPPED-FLOW TECHNIQUE AND AN IMPROVED IN-VITRO METHOD FOR HEMOGLOBIN GLYCOSYLATION, International journal of clinical pharmacology and therapeutics, 32(3), 1994, pp. 116-121

Authors: MARSCHNER JP RIETBROCK N
Citation: Jp. Marschner et N. Rietbrock, OXYGEN RELEASE KINETICS IN HEALTHY-SUBJECTS AND DIABETIC-PATIENTS .1.THE ROLE OF 2,3-DIPHOSPHOGLYCERATE, International journal of clinical pharmacology and therapeutics, 32(10), 1994, pp. 533-535

Authors: KELLERSTANISLAWSKI B CASPARY S MERZ PG BONN R WOLFF M RIETBROCK N
Citation: B. Kellerstanislawski et al., TRANSDERMAL NICOTINE SUBSTITUTION - PHARMACOKINETICS OF NICOTINE AND COTININE, International journal of clinical pharmacology, therapy and toxicology, 31(9), 1993, pp. 417-421

Authors: KEITA Y KRATZER W WORNER W RIETBROCK N
Citation: Y. Keita et al., EFFECT OF FREE FATTY-ACIDS ON THE BINDING-KINETICS AT THE BENZODIAZEPINE BINDING-SITE OF GLYCATED HUMAN SERUM-ALBUMIN, International journal of clinical pharmacology, therapy and toxicology, 31(7), 1993, pp. 337-342

Authors: WORNER W PFLEIDERER S RIETBROCK N
Citation: W. Worner et al., SELECTIVE DETERMINATION OF NONENZYMATIC GLYCOSYLATED SERUM-ALBUMIN ASA MEDIUM-TERM INDEX OF DIABETIC CONTROL, International journal of clinical pharmacology, therapy and toxicology, 31(5), 1993, pp. 218-222

Authors: MERZ PG KELLERSTANISLAWSKI B HUBER T WOODCOCK BG RIETBROCK N
Citation: Pg. Merz et al., TRANSDERMAL NICOTINE IN SMOKING CESSATION AND INVOLVEMENT OF NONSPECIFIC INFLUENCES, International journal of clinical pharmacology, therapy and toxicology, 31(10), 1993, pp. 476-482

Authors: HARDER S SIEWERT M THURMANN P BLUME H RIETBROCK N SIEWERT B
Citation: S. Harder et al., PLASMA-CONCENTRATIONS OF S-VERAPAMIL AFTER SINGLE DOSES OF 2 DIFFERENT GALENIC FORMULATIONS OF RACEMIC VERAPAMIL, Arzneimittel-Forschung, 43-1(5), 1993, pp. 520-522
Risultati: 1-21 |